Concise review for cliniciansNocardiosis: Updates and Clinical Overview
Section snippets
Risk Factors for Infection
Nocardia usually is an “opportunistic pathogen,” with the majority of infections occurring in patients with immunosuppressive conditions. Up to one-third of patients with nocardiosis, however, are immunocompetent.5 Irrespective of a patient's immunologic status, the isolation of Nocardia from the respiratory tract or other body source should not be regarded as a contaminant or commensal organism. Patients with depressed cell-mediated immunity especially are at high risk for infection, including
Clinical Presentations
Pulmonary nocardiosis is the most common clinical presentation of infection because inhalation is the primary route of bacterial exposure. The onset of symptoms may be subacute to more chronic and can include productive or nonproductive cough, shortness of breath, chest pain, hemoptysis, fever, night sweats, weight loss, and progressive fatigue. The chest radiograph can be variable, displaying focal or multifocal disease with nodular and/or consolidation infiltrate as well as cavitary lesions.18
Treatment Considerations
General treatment recommendations for nocardiosis are hindered by the lack of prospective controlled trials. Optimal antimicrobial treatment regimens have not been firmly established. Nocardia displays variable in vitro antimicrobial susceptibility patterns, and management of nocardial infections must be individualized.26 The Clinical and Laboratory Standards Institute has published recommendations for antimicrobial susceptibility testing for Nocardia and other aerobic actinomycetes.27 Nocardia
Conclusion
Increases in the number of patients receiving immunosuppressive therapies for solid organ or hematopoietic stem cell transplants, hematologic and solid tissue cancers, and autoinflammatory conditions, ensure that Nocardia will remain a formidable pathogen. Although this organism is capable of producing serious and metastatic disease in the appropriate host, early recognition and initiation of appropriate treatment can lead to successful outcomes.
References (36)
- et al.
Nocardiosis in liver transplantation: variation in presentation, diagnosis and therapy
J Infect
(1990) - et al.
Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine
Am J Gastroenterol
(2001) - et al.
Nocardiosis in adult-onset Still's disease and vasculitis syndrome
Am J Med Sci
(2008) - et al.
Nocardia brain abscess misinterpreted as cerebral infarction
J Clin Neurosci
(2003) - et al.
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest
Clin Microbiol Infect
(2006) - et al.
Antimicrobial susceptibility patterns of Nocardia asteroides
Antimicrob Agents Chemother
(1988) - et al.
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy
Clin Microbiol Rev
(2006) - et al.
Nocardia cyriacigeorgica, an emerging pathogen in the United States
J Clin Microbiol
(2008) - et al.
The medically important aerobic actinomycetes: epidemiology and microbiology
Clin Microbiol Rev
(1994) - et al.
Nocardial infections in the United States, 1972-1974
J Infect Dis
(1976)